CA9 and renal cell carcinoma: In a related study we assessed [111In]In-DOTA-HE3-ZCAIX:2 and F(ab′)2 in the non-hypoxic renal cell carcinoma model (SK-RC-52) which constitutively overexpresses CAIX because of a VHL mutation.